Persistent dysuria in women: etiological diagnostics and treatment

Abstract

INTRODUCTION: Dysuria is a painful urination combined with its frequency and/or difficulty. Dysuria is observed in many urological diseases and is one of the most common reasons for treatment for urological cause.

AIM: The aim of the study is to identify the etiological factors of dysuria in women and to evaluate a personalized approach to their treatment.

MATERIALS AND METHODS: We analyzed the data of 368 women with chronical cystitis. The inclusion criteria for the study were the presence of dysuria (painful and frequent urination more than 8 times a day with or without difficulty), the prescription of urination disorders over one year old and age 18 and over. All patients underwent a comprehensive urological examination to identify the causes of urinary disorders.

RESULTS: The Bacterial cystitis was confirmed only in 78 (21.2%) patients among all 368 women. In the remaining 290 (78.8%) patients, the causes of persistent dysuria were other diseases: bladder leukoplakia in 154 (41.8%), bladder pain syndrome/interstitial cystitis in 38 (10.3%), viral cystitis in 34 (9.3%), paraurethral formations in 29 (7.9%), neurogenic urinary dysfunction bladder in 25 (6.8%), urethral pain syndrome in 5 (1.4%) patients. Dysuria was also caused by postradiation cystitis (2 patients), secondary stones in the urinary bladder (2 patients), and one patient had extragenital endometriosis.

CONCLUSIONS: The variety of reasons for the development of persistent dysuria in women requires careful examination of patients. Treatment should be carried out only after accurate verification of the diagnosis.

Keywords

dysuria / chronic cystitis / recurrent cystitis / viral cystitis / bladder leukoplakia / painful bladder syndrome / interstitial cystitis

References

[1] Bremnor JD, Sadovsky R. Evaluation of dysuria in adults. Am Fam Physician. 2002;65(8):1589–1596.

[2] Bremnor J.D., Sadovsky R. Evaluation of dysuria in adults // Am Fam Physician. 2002. Vol. 65, No. 8. P. 1589–1596.

[3] Michels TC, Sands JE. Dysuria: Evaluation and Differential Diagnosis in Adults. Am Fam Physician. 2015;92(9):778–786.

[4] Michels T.C., Sands J.E. Dysuria: Evaluation and Differential Diagnosis in Adults // Am Fam Physician. 2015. Vol. 92, No. 9. P. 778–786.

[5] Kogan MI, Kalinichenko SYu, Avadiyeva NE. Sexual dysfunction in women with symptoms of irritation of lower urinary tract: new field of urogynecological researches. Problems of Women Health. 2008;3(4):14–17. (In Russ.)

[6] Коган М.И., Калинченко С.Ю., Авадиева Н.Э. Сексуальные дисфункции у женщин с симптомами раздражения нижних мочевых путей: новая область урогинекологических исследований // Проблемы женского здоровья. 2008. Т. 3, № 4. С. 14–17.

[7] Slesarevskaya MN, Kuzmin IV, Ignashov YuA. Characteristics of symptoms and psychosomatic status in women with chronic pelvic pain syndrome. Urologicheskie vedomosti. 2015;5(3):16–19. (In Russ.) DOI: 10.17816/uroved5316-19

[8] Слесаревская М.Н., Кузьмин И.В., Игнашов Ю.А. Особенности симптоматики и психоэмоционального статуса у женщин с синдромом хронической тазовой боли // Урологические ведомости. 2015. Т. 5, № 3. С. 16–19. DOI: 10.17816/uroved5316-19

[9] Mehta P, Leslie SW, Reddivari AKR. Dysuria. 2021 Aug 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK549918/

[10] Mehta P., Leslie S.W., Reddivari A.K.R. Dysuria. 2021 Aug 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. [Дата обращения: 05.10.21]. Доступ по ссылке: https://www.ncbi.nlm.nih.gov/books/NBK549918/

[11] Neymark AI, Chulyukova II, Mazyrko AV. Treatment of stable dysuria in women. Urology. 2003;(1):46–49. (In Russ.)

[12] Неймарк А.И., Чулюкова И.И., Мазырко А.В., и др. Лечение стойкой дизурии у женщин // Урология. 2003. № 1. С. 46–49.

[13] Loran OB, Sinjakova LA. Lejkoplakija mochevogo puzyrja kak prichina stojkoj dizurii. Medical council. 2009;(1):9–12. (In Russ.)

[14] Лоран О.Б., Синякова Л.А. Лейкоплакия мочевого пузыря как причина стойкой дизурии // Медицинский совет. 2009. № 1. С. 9–12.

[15] Neymark AI, Neymark BA, Kondrat’eva JuS. Dizuricheskij sindrom u zhenshhin. Moscow: GЕOTAR-Media; 2010. 256 p.

[16] Неймарк А.И., Неймарк Б.А., Кондратьева Ю.С. Дизурический синдром у женщин. М.: ГЭОТАР-Медиа, 2010. 256 с.

[17] Loran OB, Sinyakova LA, Vinarova NA, Nikiforov NV. Persistent dysuria in women. Current issues in diagnosis and treatment. Urology. 2013;(2):5–8. (In Russ.)

[18] Лоран О.Б., Синякова Л.А., Винарова Н.А., Никифоров Н.В. Стойкая дизурия у женщин. Актуальные вопросы диагностики и лечения // Урология. 2013. № 2. С. 5–8.

[19] Kuzmin IV. Epidemiological aspects of overactive bladder and urge urinary incontinence. Urologicheskie vedomosti. 2015;5(3): 30–34. (In Russ.) DOI: 10.17816/uroved5330-34

[20] Кузьмин И.В. Эпидемиологические аспекты гиперактивного мочевого пузыря и ургентного недержания мочи // Урологические ведомости. 2015. Т. 5, № 3. С. 30–34. DOI: 10.17816/uroved5330-34

[21] Shishkov VV, Kokurenkova PA, Il’ichjov A. Psychogenic Dysuriab. Pediatrician. 2020;11(5):73–79. (In Russ.)

[22] Шишков В.В., Кокуренкова П.А., Ильичёв А.Б., и др. Психогенная дизурия // Педиатр. 2020. Т. 11, № 5. С. 73–79. DOI: 10.17816/PED11573-79

[23] Birder LA. More than just a barrier: urothelium as a drug target for urinary bladder pain. Am J Physiol Renal Physiol. 2005;289(3): F489–F495. DOI: 10.1152/ajprenal.00467.2004

[24] Birder L.A. More than just a barrier: urothelium as a drug target for urinary bladder pain // Am J Physiol Renal Physiol. 2005. Vol. 289, No. 3. P. F489–F495. DOI: 10.1152/ajprenal.00467.2004

[25] Michel MC, Chapple CR. Basic mechanisms of urgency: preclinical and clinical evidence. Eur Urol. 2009;56(2):298–307. DOI: 10.1016/j.eururo.2009.05.028

[26] Michel M.C., Chapple C.R. Basic mechanisms of urgency: preclinical and clinical evidence // Eur Urol. 2009. Vol. 56, No. 2. P. 298–307. DOI: 10.1016/j.eururo.2009.05.028

[27] Viltsanyuk IA, Chernukha SN. Features of the differential diagnosis and treatment of a dysuria syndrome at pre- and post-menopausal age women. Crimean Journal of Internal Diseases. 2013;2(21):93–98. (In Russ.)

[28] Вильцанюк И.А., Чернуха С.Н. Особенности дифференциального диагноза и лечения синдрома дизурии у женщин пре- и постменопаузального возраста // Крымский терапевтический журнал. 2013. Т. 2, № 21. С. 93–98.

[29] Palagin IS, Sukhorukova MV, Dekhnich AV, et al. Current state of antibiotic resistance of pathogens causing community-acquired urinary tract infections in Russia, Belarus and Kazakhstan: results of the international multicenter study “Darmis-2018”. Urology. 2020;(1):19–31. (In Russ.) DOI: 10.18565/urology.2020.1.19-31

[30] Палагин И.С., Сухорукова М.В., Дехнич А.В., и др. Состояние антибиотикорезистентности возбудителей внебольничных инфекций мочевыводящих путей в России, Беларуси и Казахстане: результаты многоцентрового международного исследования «ДАРМИС-2018» // Урология. 2020. № 1. C. 19–31. DOI: 10.18565/urology.2020.1.19-31

[31] Al-Shukri SH, Slesarevskaya MN, Kuzmin IV. Use of fosfomycin in uncomplicated urinary tract infections. Urology. 2018;(5):153–159. (In Russ.) DOI: 10.18565/urology.2018.5.153-158

[32] Аль-Шукри С.Х., Слесаревская М.Н., Кузьмин И.В. Применение фосфомицина при лечении неосложненной инфекции нижних мочевыводящих путей // Урология. 2018. № 5. С. 153–159. DOI: 10.18565/urology.2018.5.153-158

[33] Kuzmin IV, Al-Shukri SH, Slesarevskaya MN. Treatment and prophylaxis of the lower urinary tract recurrent infections in women. Urologicheskie vedomosti. 2019;9(2):5–10. (In Russ.) DOI: 10.17816/uroved925-10

[34] Кузьмин И.В., Аль-Шукри С.Х., Слесаревская М.Н. Лечение и профилактика рецидивирующей инфекции нижних мочевых путей у женщин // Урологические ведомости. 2019. Т. 9, № 2. С. 5–10. DOI: 10.17816/uroved925-10

[35] Al-Shukri SH, Kuzmin IV, Slesarevskaya MN, et al. Disorders of urination in patients with chronic pelvic pain syndrome and bladder leukoplakia. Urologicheskie vedomosti. 2016;6(2):5–10. (In Russ.) DOI: 10.17816/uroved625-10

[36] Аль-Шукри С.Х., Кузьмин И.В., Слесаревская М.Н., и др. Расстройства мочеиспускания у больных с синдромом хронической тазовой боли и лейкоплакией мочевого пузыря // Урологические ведомости. 2016. Т. 6, № 2. С. 5–10. DOI: 10.17816/uroved625-10

[37] Slesarevskaya MN, Al-Shukri SKh, Sokolov AV, Kuzmin IV. Clinical course and surgical treatment of paraurethral cysts in women. Urologicheskie vedomosti. 2019;9(4):5–10. (In Russ.) DOI: 10.17816/uroved945-10

[38] Слесаревская М.Н., Аль-Шукри С.Х., Соколов А.В., Кузьмин И.В. Клиническое течение и хирургическое лечение парауретральных кистозных образований у женщин // Урологические ведомости. 2019. Т. 9, № 4. С. 5–10. DOI: 10.17816/uroved945-10

[39] Kaprin AD, Kostin AA, Semin AV, Nesterov PV. Experience of use of drug ingaron (recombinant human interferon gamma) in the treatment of radiation cystitis accompanied by hematuria. Farmateka. 2013;12(256):37–40. (In Russ.)

[40] Каприн А.Д., Костин А.А., Семин А.В., Нестеров П.В. Опыт применения препарата Ингарон® (интерферон гамма человеческий рекомбинантный) в лечении лучевых циститов, сопровождающихся гематурией // Фарматека. 2013. Т. 12, № 256. С. 37–40.

[41] Levin I, Groutz A, Gold R, et al. Surgical complications and medium-term outcome results of tension-free vaginal tape: a prospective study of 313 consecutive patients. Neurourol Urodyn. 2004;23(1):7–9. DOI: 10.1002/nau.10164

[42] Levin I., Groutz A., Gold R., et al. Surgical complications and medium-term outcome results of tension-free vaginal tape: a prospective study of 313 consecutive patients // Neurourol Urodyn. 2004. Vol. 23, No. 1. P. 7–9. DOI: 10.1002/nau.10164

[43] Maccagnano C, Pellucchi F, Rocchini L, et al. Diagnosis and treatment of bladder endometriosis: state of the art. Urol Int. 2012;89(3):249–58. DOI: 10.1159/000339519

[44] Maccagnano C., Pellucchi F., Rocchini L., et al. Diagnosis and treatment of bladder endometriosis: state of the art // Urol Int. 2012. Vol. 89, No. 3. P. 249–258. DOI: 10.1159/000339519

[45] Borisov VV. Diagnosis and therapy of urinary infections. What should always remember (clinical lecture). Part 1. Urologicheskie vedomosti. 2017;7(3):52–59. (In Russ.) DOI: 10.17816/uroved7352-59

[46] Борисов В.В. Диагностика и терапия инфекций мочевыводящих путей. О чем следует помнить всегда (клиническая лекция). Часть 1 // Урологические ведомости. 2017. Vol. 7, No. 3. P. 52–59. DOI: 10.17816/uroved7352-59

[47] Sumati AH, Saritha NK. Association of urinary tract infection in women with bacterial vaginosis. J Global Infect Dis. 2009;1(2): 151–152. DOI: 10.4103/0974-777X.56254

[48] Sumati A.H., Saritha N.K. Association of urinary tract infection in women with bacterial vaginosis // J Global Infect Dis. 2009. Vol. 1, No. 2. P. 151–152. DOI: 10.4103/0974-777X.56254

[49] Gilbert NM, O’Brien VP, Lewis AL. Transient microbiota exposures activate dormant Еscherichia coli infection in the bladder and drive severe outcomes of recurrent disease. PloS Pathog. 2017;13(3): e1006238. DOI: 10.1371/journal.ppat.1006238

[50] Gilbert N.M., O’Brien V.P., Lewis A.L. Transient microbiota exposures activate dormant Escherichia coli infection in the bladder and drive severe outcomes of recurrent disease // PloS Pathog. 2017. Vol. 13, No. 3. P. e1006238. DOI: 10.1371/journal.ppat.1006238

[51] Neymark AI, Shelkovnikova NV. Endovascular treatment of persistent dysuria and chronic pelvic pain in women with pelvic varicose veins. Urology. 2012;(4):20–24. (In Russ.)

[52] Неймарк А.И., Шелковникова Н.В. Эндоваскулярное лечение стойкой дизурии и хронических тазовых болей при варикозном расширении вен малого таза у женщин // Урология. 2012. № 4. С. 20–24.

RIGHTS & PERMISSIONS

Eco-Vector